Natera, a clinical genetic testing company, completed the acquisition of reproductive health assets from Invitae, a biotechnology company. Financial terms were not disclosed. “We are committed to providing excellent service, and we look forward to the opportunity to support additional patients and providers,” Steve Chapman, Natera CEO.